Bayer seeks EMA approval for Aflibercept for retinal vein occlusion treatment Ruchika Sharma9 April 2025 1:41 PM ISTBerlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution...
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness Ruchika Sharma15 Dec 2024 1:15 PM ISTBasel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...
LENS trial a first of its kind large scale trial shows striking 27% reduction in diabetic retinopathy progression MD Brand Connect13 Aug 2024 11:51 AM ISTPresented at the ADA Diabetes Congress 2024, the LENS TRIAL was specifically designed to investigate the effect of Fenofibrate on eye outcomes in...
Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
Roche Vabysmo prefilled syringe bags USFDA nod for three causes of vision loss Ruchika Sharma6 July 2024 4:34 PM ISTVabysmo PFS delivers the same medicine as the currently available Vabysmo vials in an alternative, ready-to-use format.
Roche Vabysmo gets CHMP recommendation for third indication retinal vein occlusion Ruchika Sharma29 Jun 2024 10:00 AM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Intravitreal dexamethasone for macular edema may increase Intraocular Pressure: Study Jacinthlyn Sylvia25 April 2024 10:00 PM ISTA comprehensive retrospective study published in the Graefe's Archive for Clinical and Experimental Ophthalmology investigated the impact of steroidal...
Roche bags USFDA nod for Vabysmo to treat retinal vein occlusion Ruchika Sharma27 Oct 2023 11:32 AM IST"Vabysmo is a new treatment option for RVO that can help people preserve and improve their vision, with the added benefit of retinal drying," said...
Vabysmo maintained vision improvements with extended treatment intervals up to 4 months for people with retinal vein occlusion in phase III studies: Roche Ruchika Sharma10 Oct 2023 2:30 PM ISTBasel: Roche has announced positive topline long-term results from the global phase III BALATON and COMINO studies, evaluating extended treatment...
Submit interim analysis results of study in Russia and India: CDSCO panel Tells Lupin Over Aflibercept Dr. Divya Colin28 Aug 2023 6:00 PM ISTNew Delhi: In response to the proposal to enroll an additional 298 patients from India in the study of the ophthalmic drug Aflibercept, the Subject...
Revise CT Protocol: CDSCO Panel Tells Roche on Ophthalmic Drug RO7200220 Dr. Divya Colin10 July 2023 6:00 PM ISTNew Delhi: Responding to the drug major Roche's proposal to conduct a Phase III clinical trial of RO7200220, anti-interleukin-6 (IL-6), the Subject...
First-line bevacizumab treatment cost-effective for CRVO or HRVO-associated macular oedema: JAMA Medha Baranwal23 May 2023 10:30 AM ISTUSA: First-line treatment with bevacizumab of macular oedema associated with central or hemiretinal vein occlusion was cost-effective in a new...
